Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary.

Galmed is an unprofitable micro cap ($94M) in the biotech space. It has less than $1M in revenue but it is showing strong revenue growth and is financially very healthy, so its fundamentals are strong and that's something that I personally like to see, even when I trade (should things

Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months. 2021-03-31 · View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. 2021-04-19 · Find the latest news headlines from Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) at Nasdaq.com. 2021-04-16 · Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research One stock that might be an intriguing choice for investors right now is Galmed Pharmaceuticals Ltd. GLMD.This is because this security in the Medical – Drugs space is seeing solid earnings 2021-04-18 · Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

1. Ki sjuksköterska schema
2. 25 moped vento retro euro4
3. Wilbur smith law firm
4. Kinafond robur
5. Arenavägen 69, stockholm, tele 2 arena
6. Stockholm taxi fare calculator

Galmed is an unprofitable micro cap ($94M) in the biotech space. It has less than $1M in revenue but it is showing strong revenue growth and is financially very healthy, so its fundamentals are strong and that's something that I personally like to see, even when I trade (should things 2020-05-14 2018-03-08 According to the market data, Galmed Pharmaceuticals Ltd (GLMD) stock price is $3.17 and the 52 weeks low is $2.96, which means the Galmed Pharmaceuticals Ltd stock price is down -21.88% in the last 12 months. Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart.. A Upward trend indicates that Galmed Pharmaceuticals Ltd Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

2018-03-08

2021-04-19 · Find the latest news headlines from Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) at Nasdaq.com. 2021-04-16 · Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart.

Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $336,116,222, with the lowest GLMD revenue forecast at $336,116,222, and the highest GLMD revenue forecast at $336,116,222.

Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis). Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD).

The all-time high Galmed Pharmaceuticals stock closing price was 17.96 on June 13, 2018. The Galmed Pharmaceuticals 52-week high stock price is 6.29, which is 79.7% above the current share price. GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices.
Bvc linero lund

Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals. GLMD updated stock price target summary. Galmed Pharmaceutica has very high historical volatility over the last 30 days: Galmed Pharmaceutica has high likelihood to experience some financial distress in the next 2 years: The company reported the previous year's revenue of 1.93 M.Net Loss for the year was (28.77 M) with profit before overhead, payroll, taxes, and interest of 2.04 M.: Galmed Pharmaceutica currently holds about 50.89 M Signals & Forecast. There are few to no technical positive signals at the moment.

Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and  Mar 21, 2021 These are 10 of the biggest stock price movers after hours for March 19, 2021. Galmed Pharmaceuticals Ltd (NASDAQ: GLMD).
Äldsta djuret

konto tullavgifter
när får man lön i sverige
swedsec test
vad ar yrkesidentitet
bästa alkoholfria ölet

• EW
• TjU
• OoG
• RxhD
• SHTWq

• Perfekta tänder
• Eds sweden
• Maktfullkomlig betyder
• Skapande aktiviteter på förskolan
• Fastator aktie
• Canteras del mundo

Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $336,116,222, with the lowest GLMD revenue forecast at $336,116,222, and the highest GLMD revenue forecast at $336,116,222.

Since then, GLMD shares have decreased by 24.5% and is now trading at $3.18. View which stocks have been most impacted by COVID-19. What price target have analysts set for GLMD? Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd. 's earnings in 2021 is -$28,771,000.. On average, 3 Wall Street analysts forecast GLMD's earnings for 2021 to be $-32,907,681, with the lowest GLMD earnings forecast at $-34,457,198, and the highest GLMD earnings forecast at $-30,229,321. If you are looking for stocks with good return, Galmed Pharmaceuticals Ltd stock can be a bad, high-risk 1-year investment option.